Welcome to your Monday morning round-up of stories in today’s edition of The Legal Intelligencer. All of the links below will take you directly to today’s stories, or you can head straight over to The Legal’s homepage. (Some stories may require registration or a paid subscription.)
The top story this morning is the First Judicial District reopening the door to allowing punitive damages in pharmaceutical cases. As reporter Amaris Elliott-Engel writes, if the Complex Litigation Center coordinating judges rule that there are sufficient requisite proofs to support the claim going to trial, the claims will be allowed to proceed.
Below the fold on Page 1, reporter Zack Needles writes that Pittsburgh-based Babst Calland has opened an Akron, Ohio, office in response to the shift occurring in the drill industry, as the focus moves away from Northeastern Pennsylvania and toward Western Pennsylvania.
In more Regional News on Page 3, reporter Saranac Hale Spencer writes that allegations that Cephalon illegally marketed its pain medication called Actiq have survived a motion from the drug company that the court reconsider its denial of summary judgment from a year ago.
In an Antitrust Law column on Page 5, Carl W. Hittinger and Lesli C. Esposito ask if it might be time for the Supreme Court to jump in regarding health care mergers.
In this week’s Law Technology News page, Kenneth Jones writes about the benefits of timeshare staffing.
If you have questions or comments about any of today's stories, or our coverage as a whole, we invite you to e-mail any of the reporters directly. We hope you'll enjoy today's Legal.